Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
205.305
USD
0.11%
Market Cap:
$363B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Abbvie Inc
NYSE:ABBV
|
US |
|
JCHX Mining Management Co Ltd
SSE:603979
|
CN |
|
Tenaris SA
NYSE:TS
|
LU |
|
Eterna Therapeutics Inc
NASDAQ:ERNA
|
US |
|
Macrotech Developers Ltd
BSE:543287
|
IN |
|
Cogeco Communications Inc
TSX:CCA
|
CA |
|
Menon Pistons Ltd
BSE:531727
|
IN |
|
W
|
Wattana Karnpaet PCL
SET:NEW
|
TH |
|
Beijing Originwater Technology Co Ltd
SZSE:300070
|
CN |
|
Hazama Ando Corp
TSE:1719
|
JP |
Relative Value
The Relative Value of one
ABBV
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 205.305 USD,
Abbvie Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ABBV Relative Value
HIDDEN
Multiples Across Competitors
ABBV Competitors Multiples
Abbvie Inc Competitors
Abbvie Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.7 | 14.4 | 20 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.2 | 24.6 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20.1 | 12.6 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.1 | 21.9 | 22.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 34.3 | 11.3 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 10.9 | 129.4 | 72.4 | 80.4 | |
| NL |
|
argenx SE
XBRU:ARGX
|
35.8B EUR | 10.3 | 33.1 | 35.8 | 36.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
